Back to Insider Trading View Full Company Profile

FOLD

UNKNOWN

AMICUS THERAPEUTICS, INC.

CIK: 0001178879

Strong Sell (90% confidence)

Last activity: 3 weeks ago

Financial Metrics

As of Dec 31, 2024 (10-K)

Total Cash $213.75M

Insider Roster (4 total, 4 active)

Insider Buys Sells Net Value Holdings
Campbell Bradley L
President and CEO
0 4 -$2.21M
1,021,180 shares
$14.61M
Rosenberg Ellen
Chief Legal Officer
0 3 -$958K
507,710 shares
$5.08M
Clark David Michael
Chief People Officer
0 3 -$904K
245,690 shares
$3.48M
Castelli Jeff
Chief Development Officer
0 1 -$774K
439,318 shares
$4.46M

Recent Transactions

SELL Campbell Bradley L (President and CEO)

75,000 shares @ $14.31

$1.07M

Jan 20, 2026

Conviction: | View SEC Filing →
SELL Clark David Michael (Chief People Officer)

25,642 shares @ $14.17

$363K

Dec 19, 2025

Conviction: | View SEC Filing →
SELL Campbell Bradley L (President and CEO)

77,926 shares @ $10.86

$846K

Dec 15, 2025

Conviction: | View SEC Filing →
SELL Clark David Michael (Chief People Officer)

25,643 shares @ $11.00

$282K

Dec 15, 2025

Conviction: | View SEC Filing →
SELL Campbell Bradley L (President and CEO)

14,587 shares @ $10.01

$146K

Dec 1, 2025

Conviction: | View SEC Filing →
SELL Rosenberg Ellen (Chief Legal Officer)

23,621 shares @ $10.00

$236K

Nov 26, 2025

Conviction: | View SEC Filing →
SELL Rosenberg Ellen (Chief Legal Officer)

36,000 shares @ $10.00

$360K

Nov 25, 2025

Conviction: | View SEC Filing →
SELL Castelli Jeff (Chief Development Officer)

76,158 shares @ $10.16

$774K

Nov 24, 2025

Conviction: | View SEC Filing →
SELL Rosenberg Ellen (Chief Legal Officer)

36,000 shares @ $10.06

$362K

Nov 24, 2025

Conviction: | View SEC Filing →
SELL Clark David Michael (Chief People Officer)

25,643 shares @ $10.10

$259K

Nov 24, 2025

Conviction: | View SEC Filing →
SELL Campbell Bradley L (President and CEO)

14,587 shares @ $10.04

$147K

Nov 24, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.